CRBPCorbus Pharmaceuticals Hold...

Nasdaq corbuspharma.com


$ 52.69 $ 2.67 (5.34 %)    

Monday, 09-Sep-2024 15:59:44 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 52.71
$ 51.49
$ 52.54 x 105
-- x --
$ 51.49 - $ 54.49
$ 3.03 - $ 61.90
199,192
na
634.84M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-12-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-07-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-08-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-15-2021 12-31-2020 10-K
16 11-09-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-16-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-12-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 03-12-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-09-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 03-08-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-12-2016 06-30-2016 10-Q
34 05-13-2016 03-31-2016 10-Q
35 03-28-2016 12-31-2015 10-K
36 11-10-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-13-2015 03-31-2015 10-Q
39 02-10-2015 12-31-2014 10-K
40 11-13-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cannabis-stocks-react-to-trumps-marijuana-comments-see-which-ones-posted-solid-gains

Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday.

 rbc-capital-reiterates-outperform-on-corbus-pharmaceuticals-maintains-82-price-target

RBC Capital analyst Brian Abrahams reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and maintains $82 price...

 rbc-capital-reiterates-outperform-on-corbus-pharmaceuticals-maintains-82-price-target

RBC Capital analyst Brian Abrahams reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and maintains $82 price...

 oppenheimer-maintains-outperform-on-corbus-pharmaceuticals-raises-price-target-to-88

Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and raises the price target ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION